Prevention of fractures after solid organ transplantation: A meta-analysis

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 11, 2011, Pages 3457-3465

  Stein, Emily M ^a   Ortiz, Dionisio ^a   Jin, Zhezhen ^b   McMahon, Donald J ^a   Shane, Elizabeth ^a  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

^b Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1ALPHA HYDROXYVITAMIN D; ALENDRONIC ACID; ALFACALCIDOL; CALCITRIOL; CALCIUM; COLECALCIFEROL; ERGOCALCIFEROL; IBANDRONIC ACID; PAMIDRONIC ACID; PLACEBO; UNCLASSIFIED DRUG; VITAMIN D DERIVATIVE; ZOLEDRONIC ACID;

ARTICLE; BONE DENSITY; BONE FRAGILITY; CONTROLLED STUDY; DRUG EFFICACY; FEMUR NECK; GRAFT RECIPIENT; HUMAN; INTERVENTION STUDY; LUMBAR SPINE; MAJOR CLINICAL STUDY; META ANALYSIS; ORGAN TRANSPLANTATION; OSTEOLYSIS; OUTCOMES RESEARCH; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SOLID ORGAN TRANSPLANTATION; SYSTEMATIC REVIEW; TREATMENT RESPONSE; VERTEBRA FRACTURE;

BONE DENSITY; DIPHOSPHONATES; FRACTURES, BONE; HUMANS; ORGAN TRANSPLANTATION; POSTOPERATIVE PERIOD; VITAMIN D;

EID: 80655145200     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-1448     Document Type: Article

References (42)

1. Jalava T, Sarna S, Pylkkänen L, Mawer B, Kanis JA, Selby P, Davies M, Adams J, Francis RM, Robinson J, McCloskey E 2003 Association between vertebral fracture and increased mortality in osteoporotic patients. J Bone Miner Res 18:1254-1260 (Pubitemid 37294918)
2. Browner WS, Pressman AR, Nevitt MC, Cummings SR 1996 Mortality following fractures in older women. The study of osteoporotic fractures. Arch Intern Med 156:1521-1525
3. Stein E, Ebeling P, Shane E 2007 Post-transplantation osteoporosis. Endocrinol Metab Clin North Am 36:937-963; viii
4. Stein E, Compston J, Shane E 2009 Transplantation osteoporosis. In: Bilezikian JP, ed. Osteoporosis in men. London: Elsevier; 443-452
5. Shane E, Addesso V, Namerow PB, McMahon DJ, Lo SH, Staron RB, Zucker M, Pardi S, Maybaum S, Mancini D 2004 Alendronate versus calcitriol for the prevention of bone loss after cardiac transplantation. N Engl J Med 350:767-776 (Pubitemid 38209646)
6. Mikuls TR, Julian BA, Bartolucci A, Saag KG 2003 Bone mineral density changes within six months of renal transplantation. Transplantation 75:49-54 (Pubitemid 36139694)
7. Julian BA, Laskow DA, Dubovsky J, Dubovsky EV, Curtis JJ, Quarles LD 1991 Rapid loss of vertebral mineral density after renal transplantation. N Engl J Med 325:544-550
8. Leidig-Bruckner G, Hosch S, Dodidou P, Ritschel D, Conradt C, Klose C, Otto G, Lange R, Theilmann L, Zimmerman R, Pritsch M, Ziegler R 2001 Frequency and predictors of osteoporotic fractures after cardiac or liver transplantation: a follow-up study. Lancet 357:342-347 (Pubitemid 32128540)
9. Guichelaar MM, Kendall R, Malinchoc M, Hay JE 2006 Bone mineral density before and after OLT: long-term follow-up and predictive factors. Liver Transpl 12:1390-1402 (Pubitemid 44405129)
10. Shane E, Papadopoulos A, Staron RB, Addesso V, Donovan D, McGregor C, Schulman LL 1999 Bone loss and fracture after lung transplantation. Transplantation 68:220-227 (Pubitemid 29360280)
11. Spira A, Gutierrez C, Chaparro C, Hutcheon MA, Chan CK 2000 Osteoporosis and lung transplantation: a prospective study. Chest 117:476-481 (Pubitemid 30111601)
12. Shane E, Rivas M, McMahon DJ, Staron RB, Silverberg SJ, Seibel MJ, Mancini D, Michler RE, Aaronson K, Addesso V, Lo SH 1997 Bone loss and turnover after cardiac transplantation. J Clin Endocrinol Metab 82:1497-1506 (Pubitemid 27200425)
13. Shane E, Rivas M, Staron RB, Silverberg SJ, Seibel MJ, Kuiper J, Mancini D, Addesso V, Michler RE, Factor-Litvak P 1996 Fracture after cardiac transplantation: a prospective longitudinal study. J Clin Endocrinol Metab 81:1740-1746 (Pubitemid 26152456)
14. Ninkovic M, Love S, Tom BD, Bearcroft PW, Alexander GJ, Compston JE 2002 Lack of effect of intravenous pamidronate on fracture incidence and bone mineral density after orthotopic liver transplantation. J Hepatol 37:93-100 (Pubitemid 34713060)
15. Aringer M, Kiener HP, Koeller MD, Artemiou O, Zuckermann A, Wieselthaler G, Klepetko W, Seidl G, Kainberger F, Bernecker P, Smolen JS, Pietschmann P 1998 High turnover bone disease following lung transplantation. Bone 23:485-488 (Pubitemid 28470620)
16. Crawford BA, Kam C, Pavlovic J, Byth K, Handelsman DJ, Angus PW, McCaughan GW 2006 Zoledronic acid prevents bone loss after liver transplantation: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 144:239-248 (Pubitemid 46768206)
17. Coco M, Glicklich D, Faugere MC, Burris L, Bognar I, Durkin P, Tellis V, Greenstein S, Schechner R, Figueroa K, McDonough P, Wang G, Malluche H 2003 Prevention of bone loss in renal transplant recipients: a prospective, randomized trial of intravenous pamidronate. J Am Soc Nephrol 14:2669-2676 (Pubitemid 37169355)
18. De Sévaux RG, Hoitsma AJ, Corstens FH, Wetzels JF 2002 Treatment with vitamin D and calcium reduces bone loss after renal transplantation: a randomized study. J Am Soc Nephrol 13:1608-1614 (Pubitemid 34579249)
19. Fahrleitner-Pammer A, Piswanger-Soelkner JC, Pieber TR, Obermayer-Pietsch BM, Pilz S, Dimai HP, Prenner G, Tscheliessnigg KH, Hauge E, Portugaller RH, Dobnig H 2009 Ibandronate prevents bone loss and reduces vertebral fracture risk in male cardiac transplant patients: a randomized double-blind, placebo-controlled trial. J Bone Miner Res 24:1335-1344
20. Grotz W, Nagel C, Poeschel D, Cybulla M, Petersen KG, Uhl M, Strey C, Kirste G, Olschewski M, Reichelt A, Rump LC 2001 Effect of ibandronate on bone loss and renal function after kidney transplantation. J Am Soc Nephrol 12:1530-1537 (Pubitemid 32666337)
21. Walsh SB, Altmann P, Pattison J, Wilkie M, Yaqoob MM, Dudley C, Cockwell P, Sweny P, Banks LM, Hall-Craggs M, Noonan K, Andrews C, Cunningham J 2009 Effect of pamidronate on bone loss after kidney transplantation: a randomized trial. Am J Kidney Dis 53:856-865
22. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ 1996 Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17:1-12 (Pubitemid 26120810)
23. Sambrook P, Henderson NK, Keogh A, MacDonald P, Glanville A, Spratt P, Bergin P, Ebeling P, Eisman J 2000 Effect of calcitriol on bone loss after cardiac or lung transplantation. J Bone Miner Res 15:1818-1824 (Pubitemid 30666235)
24. Schwarz C, Mitterbauer C, Heinze G, Woloszczuk W, Haas M, Oberbauer R 2004 Nonsustained effect of short-term bisphosphonate therapy on bone turnover three years after renal transplantation. Kidney Int 65:304-309 (Pubitemid 38037518)
25. Sutton AJ, Abrams KR, Jones DR, Sheldon TA, Song F 2000 Methods for meta-analysis in medical research. New York: Wiley
26. Monegal A, Guanabens N, Suarez MJ, Suarez F, Clemente G, Garcia-Gonzalez M, De la Mata M, Serrano T, Casafont F, Torne S, Barrios C, Navasa M 2009 Pamidronate in the prevention of bone loss after liver transplantation: a randomized controlled trial. Transpl Int 22:198-206
27. Bodingbauer M, Wekerle T, Pakrah B, Roschger P, Peck-Radosavljevic M, Silberhumer G, Grampp S, Rockenschaub S, Berlakovich G, Steininger R, Klaushofer K, Oberbauer R, Mühlbacher F 2007 Prophylactic bisphosphonate treatment prevents bone fractures after liver transplantation. Am J Transplant 7:1763-1769 (Pubitemid 46905434)
28. Gil-Fraguas L, Jodar E, Martinez G, Escalona MA, Vara J, Robles E, Hawkins F 2005 Evolution of bone density after heart transplantation: influence of anti-resorptive therapy. J Bone Miner Res 20(Suppl 1):S439-S440
29. Garcia-Delgado I, Prieto S, Gil-Fraguas L, Robles E, Rufilanchas JJ, Hawkins F 1997 Calcitonin, editronate and calcidiol treatment in bone loss after cardiac transplantation. Calcif Tissue Int 60:155-159 (Pubitemid 27057499)
30. Grotz WH, Rump LC, Niessen A, Schmidt-Gayk H, Reichelt A, Kirste G, Olchewski M, Schollmeyer PJ 1998 Treatment of osteopenia and osteoporosis after kidney transplantation. Transplantation 66:1004-1008 (Pubitemid 28513378)
31. Valero M, Loinaz C, Larrodera L, Leon M, Moreno E, Hawkins F 1995 Calcitonin and bisphosphonate treatment in bone loss after liver transplantation. Calcif Tissue Int 57:15-19
32. Kaemmerer D, Lehmann G, Wolf G, Settmacher U, Hommann M 2010 Treatment of osteoporosis after liver transplantation with ibandronate. Transpl Int 23:753-759
33. Goffin E, Devogelaer JP, Lalaoui A, Depresseux G, De Naeyer P, Squifflet JP, Pirson Y, van Ypersele de Strihou C 2002 Tacrolimus and low-dose steroid immunosuppression preserves bone mass after renal transplantation. Transpl Int 15:73-80
34. Rutherford RM, Fisher AJ, Hilton C, Forty J, Hasan A, Gould FK, Dark JH, Corris PA 2005 Functional status and quality of life in patients surviving 10 years after lung transplantation. Am J Transplant 5:1099-1104 (Pubitemid 40571260)
35. Monegal A, Navasa M, Guañabens N, Peris P, Pons F, Martínez de Osaba MJ, Rimola A, Rodés J, Muñoz-Gómez J 2001 Bone mass and mineral metabolism in liver transplant patients treated with FK506 or cyclosporine A. Calcif Tissue Int 68:83-86 (Pubitemid 32289863)
36. Mitterbauer C, Schwarz C, Haas M, Oberbauer R 2006 Effects of bisphosphonates on bone loss in the first year after renal transplantation - a meta-analysis of randomized controlled trials. Nephrol Dial Transplant 21:2275-2281
37. de Nijs RN, Jacobs JW, Algra A, Lems WF, Bijlsma JW 2004 Prevention and treatment of glucocorticoid-induced osteoporosis with active vitamin D3 analogues: a review with meta-analysis of randomized controlled trials including organ transplantation studies. Osteoporos Int 15:589-602
38. Kasturi KS, Chennareddygari S, Mummadi RR 2010 Effect of bisphosphonates on bone mineral density in liver transplant patients: a meta-analysis and systematic review of randomized controlled trials. Transpl Int 23:200-207
39. Palmer SC, Strippoli GF, McGregor DO 2005 Interventions for preventing bone disease in kidney transplant recipients: a systematic review of randomized controlled trials. Am J Kidney Dis 45:638-649 (Pubitemid 40460752)
40. Pichette V, Bonnardeaux A, Prudhomme L, Gagné M, Cardinal J, Ouimet D 1996 Long-term bone loss in kidney transplant recipients: a cross-sectional and longitudinal study. Am J Kidney Dis 28:105-114 (Pubitemid 26231474)
41. Grotz WH, Mundinger FA, Gugel B, Exner V, Kirste G, Schollmeyer PJ 1994 Bone fracture and osteodensitometry with dual energy Xray absorptiometry in kidney transplant recipients. Transplantation 58:912-915 (Pubitemid 24333282)
42. Monegal A, Navasa M, Guañabens N, Peris P, Pons F, Martinez de Osaba MJ, Ordi J, Rimola A, Rodés J, Muñoz-Gómez J 2001 Bone disease after liver transplantation: a long-term prospective study of bone mass changes, hormonal status and histomorphometric characteristics. Osteoporos Int 12:484-492 (Pubitemid 32607092)